Evaluation of Covid 19 Anxiety in Endometriosis Patients

Endometriosis Patients Covid 19 Anxiety

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04337346

Enrollment

Registered

2020-04-07

Start date

2020-04-05

Completion date

2020-04-25

Last updated

2020-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Endometriosis

Brief summary

It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* endometriosis patients * no psychiatric illness * no antidepressant use

Exclusion criteria

* women who had not endometriosis * no extra health conditions * women younger than 18 and older than 45

Design outcomes

Primary

Measure	Time frame	Description
Covid 19 Anxiety levels in Endometriosis Patients	20 days	The Beck Anxiety Inventory (BAI); it measures the frequency of anxiety symptoms experienced by the patient. It consists of 21 questions in total. Each item gets an increasing score between 0-3. The total score ranges from 0 - 63. The following guidelines are recommended for the interpretation of scores: 0 -9, normal or no anxiety; 10 -18, mild to moderate anxiety; 19 -29, moderate to severe anxiety; and 30 - 63, severe anxiety.

Countries

Turkey (Türkiye)

Outcome results